Adma Biologics, Inc. SEC filings ADMA

Adma Biologics, Inc. has 999 filings in SEC EDGAR's recent list, going back to Jul 10, 2006. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 15, 2026 Dec 31, 2025
10-K Annual report Feb 25, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 15, 2025 Dec 31, 2024
10-K Annual report Mar 18, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 15, 2024 Dec 31, 2023
10-K Annual report Feb 28, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 13, 2023 Dec 31, 2022
10-K Annual report Mar 23, 2023 Dec 31, 2022
10-K Annual report Mar 24, 2022 Dec 31, 2021
10-K Annual report Mar 25, 2021 Dec 31, 2020
10-K Annual report Mar 13, 2020 Dec 31, 2019
10-K Annual report Mar 13, 2019 Dec 31, 2018
10-K Annual report Mar 29, 2018 Dec 31, 2017
10-K Annual report Feb 24, 2017 Dec 31, 2016
10-K Annual report Mar 23, 2016 Dec 31, 2015
10-K Annual report Mar 9, 2015 Dec 31, 2014
ARS Annual report to shareholders May 27, 2014 Dec 31, 2013
10-K Annual report Mar 28, 2014 Dec 31, 2013
10-K/A Amended annual report Apr 30, 2013 Dec 31, 2012
10-K Annual report Mar 6, 2013 Dec 31, 2012
10-K Annual report Sep 27, 2011 Jun 30, 2011
10-K Annual report Sep 23, 2010 Jun 30, 2010
10-K Annual report Sep 24, 2009 Jun 30, 2009

Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ADMA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Ramsey, NJ
SEC filer status
Large accelerated filer
SEC CIK
1368514
Former names
R&R ACQUISITION VI, INC (until Feb 21, 2012)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.